Medicine and Dentistry
Percutaneous Coronary Intervention
100%
ST Segment Elevation Myocardial Infarction
76%
Rapamycin
70%
Primary Percutaneous Coronary Intervention
51%
Stent Thrombosis
46%
Myocardial Infarction
42%
Drug-Eluting Stent
40%
Stenting
33%
Coronary Bifurcation Lesion
32%
Disease
26%
Out of Hospital Cardiac Arrest
26%
Hazard Ratio
26%
Diabetes Mellitus
24%
Acute Heart Infarction
23%
Angiography
22%
Coronary Artery
22%
Major Adverse Cardiac Event
21%
Optical Coherence Tomography
21%
Zotarolimus
21%
Revascularization
19%
Intravascular Ultrasound
19%
Target Lesion Revascularization
18%
Coronary Artery Disease
17%
Everolimus
17%
Resuscitation
17%
Coronary Angiography
17%
Paclitaxel
16%
Umirolimus
15%
Randomized Controlled Trial
15%
Heart Death
15%
Infarction
14%
Ticagrelor
14%
Fractional Flow Reserve
14%
Diabetes
13%
Health Care
12%
Stable Angina Pectoris
12%
Target Vessel Revascularization
12%
Computed Tomography Angiography
11%
Odds Ratio
10%
Patient with Diabetes
10%
Elution
10%
Stenosis
10%
Acute Coronary Syndrome
10%
Noninferiority Trial
9%
Coronary Artery Obstruction
9%
Cardiogenic Shock
9%
Antithrombotic
9%
Anticoagulant Therapy
9%
Non ST Segment Elevation Myocardial Infarction
9%
Ischemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
66%
Heart Infarction
45%
Rapamycin
45%
Stent Thrombosis
40%
Umirolimus
21%
Acute Heart Infarction
19%
Anticoagulant Agent
18%
Ticagrelor
17%
Infarction
15%
Major Adverse Cardiac Event
13%
Heart Death
13%
Disease
13%
Everolimus
12%
All Cause Mortality
12%
Coronary Bifurcation Lesion
10%
Randomized Controlled Trial
10%
Ischemic Heart Disease
10%
Diabetes Mellitus
10%
Out of Hospital Cardiac Arrest
10%
Paclitaxel
10%
Noninferiority Trial
10%
Coronary Artery Disease
9%
Cerebrovascular Accident
9%
Bleeding
8%
Acute Coronary Syndrome
7%
Cardiovascular Disease
7%
Stable Angina Pectoris
7%
Antiplatelet
7%
Stenosis
7%
Peripheral Occlusive Artery Disease
7%
Zotarolimus
7%
Clinical Trial
6%
Randomized Clinical Trial
6%
Congestive Heart Failure
6%
Prothrombin
6%
Ischemia
6%
Heparin
5%
Prevalence
5%
Cohort Study
5%
Mortality Rate
5%
Nursing and Health Professions
Percutaneous Coronary Intervention
38%
ST Segment Elevation Myocardial Infarction
28%
Stent
13%
Coronary Angiography
11%
Out of Hospital Cardiac Arrest
10%
Anticoagulant Agent
10%
Resuscitation
9%
Anticoagulant Therapy
8%
Confidence Interval
7%
General Practice
7%
Fractional Flow Reserve
7%
Acute Heart Infarction
7%
Stable Angina Pectoris
6%
Clinical Outcome
6%
Revascularization
5%
Healthcare System
5%
Computed Tomographic Angiography
5%
Peripheral Occlusive Artery Disease
5%
Heart Infarction
5%